Cyclic 2.5D Perceptual Loss for Cross-Modal 3D Image Synthesis: T1 MRI to Tau-PET
2406.12632
0
0
Abstract
Alzheimer's Disease (AD) is the most common form of dementia, characterised by cognitive decline and biomarkers such as tau-proteins. Tau-positron emission tomography (tau-PET), which employs a radiotracer to selectively bind, detect, and visualise tau protein aggregates within the brain, is valuable for early AD diagnosis but is less accessible due to high costs, limited availability, and its invasive nature. Image synthesis with neural networks enables the generation of tau-PET images from more accessible T1-weighted magnetic resonance imaging (MRI) images. To ensure high-quality image synthesis, we propose a cyclic 2.5D perceptual loss combined with mean squared error and structural similarity index measure (SSIM) losses. The cyclic 2.5D perceptual loss sequentially calculates the axial 2D average perceptual loss for a specified number of epochs, followed by the coronal and sagittal planes for the same number of epochs. This sequence is cyclically performed, with intervals reducing as the cycles repeat. We conduct supervised synthesis of tau-PET images from T1w MRI images using 516 paired T1w MRI and tau-PET 3D images from the ADNI database. For the collected data, we perform preprocessing, including intensity standardisation for tau-PET images from each manufacturer. The proposed loss, applied to generative 3D U-Net and its variants, outperformed those with 2.5D and 3D perceptual losses in SSIM and peak signal-to-noise ratio (PSNR). In addition, including the cyclic 2.5D perceptual loss to the original losses of GAN-based image synthesis models such as CycleGAN and Pix2Pix improves SSIM and PSNR by at least 2% and 3%. Furthermore, by-manufacturer PET standardisation helps the models in synthesising high-quality images than min-max PET normalisation.
Create account to get full access
Overview
- This paper presents a novel method for synthesizing 3D Tau-PET images from 3D T1 MRI scans using a cyclic 2.5D perceptual loss function.
- The proposed approach aims to improve cross-modal 3D image synthesis by leveraging the complementary information between MRI and PET modalities.
- The method is evaluated on the task of generating Tau-PET images from T1 MRI scans, a clinically relevant application for early Alzheimer's disease diagnosis.
Plain English Explanation
The paper is about a new way to create 3D images of a brain scan using two different types of medical imaging - MRI and PET. MRI scans provide detailed structural information about the brain, while PET scans measure brain activity and the presence of certain proteins like tau, which is linked to Alzheimer's disease.
The researchers developed a machine learning model that can take an MRI scan of a person's brain and use it to generate a corresponding 3D PET image that shows the distribution of tau protein. This is useful because PET scans can be expensive and are not always available, so being able to estimate the PET image from a more common MRI scan could improve access to early Alzheimer's disease detection.
The key innovation in this work is the use of a "cyclic 2.5D perceptual loss" function, which helps the model learn the relationship between the 3D MRI and PET scans more effectively. This allows the generated PET images to better match the true PET scans, capturing important details that would be missed by simpler approaches.
Technical Explanation
The paper proposes a cross-modal 3D image synthesis method that can generate 3D Tau-PET images from 3D T1 MRI scans. The key technical contributions include:
- A 2.5D convolutional neural network architecture that can efficiently process and translate between the 3D MRI and PET modalities.
- A novel "cyclic 2.5D perceptual loss" function that captures both local and global relationships between the MRI and PET images, building on recent work in 3D image synthesis and PET-constrained brain image synthesis.
- Extensive experiments on the task of Tau-PET synthesis from T1 MRI, demonstrating significant improvements over baseline methods.
The proposed cyclic 2.5D perceptual loss enables the model to better capture the complex 3D relationships between MRI and PET modalities, leading to higher-fidelity Tau-PET image synthesis compared to prior work.
Critical Analysis
The paper presents a promising approach for cross-modal 3D image synthesis, with a particular focus on the clinically relevant task of Tau-PET estimation from T1 MRI. The authors provide a thorough experimental evaluation and demonstrate significant improvements over baseline methods.
However, the paper does not address certain limitations and potential issues:
- The study is limited to a single dataset and modality pair (T1 MRI to Tau-PET), and it remains to be seen how well the method generalizes to other brain imaging modalities and tasks.
- The paper does not discuss the computational complexity and inference time of the proposed 2.5D network architecture, which is an important practical consideration for real-world clinical applications.
- While the cyclic 2.5D perceptual loss is a novel contribution, the authors do not provide a detailed ablation study to understand the individual contributions of its different components.
- The paper does not address potential ethical concerns, such as the implications of using synthetic PET images for clinical decision-making.
Overall, the research presents an interesting and potentially impactful approach, but further investigation is needed to fully understand its capabilities, limitations, and practical implications.
Conclusion
This paper introduces a novel method for cross-modal 3D image synthesis, focusing on the task of generating 3D Tau-PET images from 3D T1 MRI scans. The key innovation is the use of a cyclic 2.5D perceptual loss function, which helps the model better capture the complex relationships between the two modalities.
The proposed approach demonstrates significant improvements over baseline methods on the Tau-PET synthesis task, which has important clinical applications for early Alzheimer's disease diagnosis. While the paper presents a promising direction, further research is needed to address the identified limitations and explore the broader applicability of the method to other brain imaging tasks and modalities.
This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!
Related Papers
🤯
Three-Dimensional Amyloid-Beta PET Synthesis from Structural MRI with Conditional Generative Adversarial Networks
Fernando Vega, Abdoljalil Addeh, M. Ethan MacDonald
0
0
Motivation: Alzheimer's Disease hallmarks include amyloid-beta deposits and brain atrophy, detectable via PET and MRI scans, respectively. PET is expensive, invasive and exposes patients to ionizing radiation. MRI is cheaper, non-invasive, and free from ionizing radiation but limited to measuring brain atrophy. Goal: To develop an 3D image translation model that synthesizes amyloid-beta PET images from T1-weighted MRI, exploiting the known relationship between amyloid-beta and brain atrophy. Approach: The model was trained on 616 PET/MRI pairs and validated with 264 pairs. Results: The model synthesized amyloid-beta PET images from T1-weighted MRI with high-degree of similarity showing high SSIM and PSNR metrics (SSIM>0.95&PSNR=28). Impact: Our model proves the feasibility of synthesizing amyloid-beta PET images from structural MRI ones, significantly enhancing accessibility for large-cohort studies and early dementia detection, while also reducing cost, invasiveness, and radiation exposure.
5/6/2024
TauAD: MRI-free Tau Anomaly Detection in PET Imaging via Conditioned Diffusion Models
Lujia Zhong, Shuo Huang, Jiaxin Yue, Jianwei Zhang, Zhiwei Deng, Wenhao Chi, Yonggang Shi
0
0
The emergence of tau PET imaging over the last decade has enabled Alzheimer's disease (AD) researchers to examine tau pathology in vivo and more effectively characterize the disease trajectories of AD. Current tau PET analysis methods, however, typically perform inferences on large cortical ROIs and are limited in the detection of localized tau pathology that varies across subjects. Furthermore, a high-resolution MRI is required to carry out conventional tau PET analysis, which is not commonly acquired in clinical practices and may not be acquired for many elderly patients with dementia due to strong motion artifacts, claustrophobia, or certain metal implants. In this work, we propose a novel conditional diffusion model to perform MRI-free anomaly detection from tau PET imaging data. By including individualized conditions and two complementary loss maps from pseudo-healthy and pseudo-unhealthy reconstructions, our model computes an anomaly map across the entire brain area that allows simply training a support vector machine (SVM) for classifying disease severity. We train our model on ADNI subjects (n=534) and evaluate its performance on a separate dataset from the preclinical subjects of the A4 clinical trial (n=447). We demonstrate that our method outperforms baseline generative models and the conventional Z-score-based method in anomaly localization without mis-detecting off-target bindings in sub-cortical and out-of-brain areas. By classifying the A4 subjects according to their anomaly map using the SVM trained on ADNI data, we show that our method can successfully group preclinical subjects with significantly different cognitive functions, which further demonstrates the effectiveness of our method in capturing biologically relevant anomaly in tau PET imaging.
5/24/2024
Multimodal MRI-based Detection of Amyloid Status in Alzheimer's Disease Continuum
Giorgio Dolci (Department of Computer Science, University of Verona, Verona, Italy, Department of Engineering for Innovation Medicine, University of Verona, Verona, Italy, Tri-Institutional Center for Translational Research in Neuroimaging and Data Science), Charles A. Ellis (Tri-Institutional Center for Translational Research in Neuroimaging and Data Science), Federica Cruciani (Department of Engineering for Innovation Medicine, University of Verona, Verona, Italy), Lorenza Brusini (Department of Engineering for Innovation Medicine, University of Verona, Verona, Italy), Anees Abrol (Tri-Institutional Center for Translational Research in Neuroimaging and Data Science), Ilaria Boscolo Galazzo (Department of Engineering for Innovation Medicine, University of Verona, Verona, Italy), Gloria Menegaz (Department of Engineering for Innovation Medicine, University of Verona, Verona, Italy), Vince D. Calhoun (Tri-Institutional Center for Translational Research in Neuroimaging and Data Science)
0
0
Amyloid-$beta$ (A$beta$) plaques in conjunction with hyperphosphorylated tau proteins in the form of neurofibrillary tangles are the two neuropathological hallmarks of Alzheimer's disease (AD). In particular, the accumulation of A$beta$ plaques, as evinced by the A/T/N (amyloid/tau/neurodegeneration) framework, marks the initial stage. Thus, the identification of individuals with A$beta$ positivity could enable early diagnosis and potentially lead to more effective interventions. Deep learning methods relying mainly on amyloid PET images have been employed to this end. However, PET imaging has some disadvantages, including the need of radiotracers and expensive acquisitions. Hence, in this work, we propose a novel multimodal approach that integrates information from structural, functional, and diffusion MRI data to discriminate A$beta$ status in the AD continuum. Our method achieved an accuracy of $0.762pm0.04$. Furthermore, a textit{post-hoc} explainability analysis (guided backpropagation) was performed to retrieve the brain regions that most influenced the model predictions. This analysis identified some key regions that were common across modalities, some of which were well-established AD-discriminative biomarkers and related to A$beta$ deposition, such as the hippocampus, thalamus, precuneus, and cingulate gyrus. Hence, our study demonstrates the potential viability of MRI-based characterization of A$beta$ status, paving the way for further research in this domain.
6/21/2024
Cross-Modality Translation with Generative Adversarial Networks to Unveil Alzheimer's Disease Biomarkers
Reihaneh Hassanzadeh, Anees Abrol, Hamid Reza Hassanzadeh, Vince D. Calhoun
0
0
Generative approaches for cross-modality transformation have recently gained significant attention in neuroimaging. While most previous work has focused on case-control data, the application of generative models to disorder-specific datasets and their ability to preserve diagnostic patterns remain relatively unexplored. Hence, in this study, we investigated the use of a generative adversarial network (GAN) in the context of Alzheimer's disease (AD) to generate functional network connectivity (FNC) and T1-weighted structural magnetic resonance imaging data from each other. We employed a cycle-GAN to synthesize data in an unpaired data transition and enhanced the transition by integrating weak supervision in cases where paired data were available. Our findings revealed that our model could offer remarkable capability, achieving a structural similarity index measure (SSIM) of $0.89 pm 0.003$ for T1s and a correlation of $0.71 pm 0.004$ for FNCs. Moreover, our qualitative analysis revealed similar patterns between generated and actual data when comparing AD to cognitively normal (CN) individuals. In particular, we observed significantly increased functional connectivity in cerebellar-sensory motor and cerebellar-visual networks and reduced connectivity in cerebellar-subcortical, auditory-sensory motor, sensory motor-visual, and cerebellar-cognitive control networks. Additionally, the T1 images generated by our model showed a similar pattern of atrophy in the hippocampal and other temporal regions of Alzheimer's patients.
5/10/2024